Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner

W Guo1, Y Zhang2, Z Ling3

  • 1Department of Abdominal Oncology, State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17# People's South Road, Chengdu, Chengdu 610041, PR China.

Cell Death & Disease
|October 16, 2015
PubMed

Insights

Genistein induces cancer cell death independently of Bax or p53, offering a potential treatment for chemoresistance. This compound activates cell death pathways involving Bak, AIF, and endoG, even when Bax or p53 are deficient.

Area of Science:

  • * Molecular Biology
  • * Cancer Research
  • * Cell Death Mechanisms

Background:

  • * Chemoresistance in cancer is often linked to gene mutations or deficiencies, such as in Bax or p53.
  • * Existing cancer therapies face challenges when tumors develop resistance due to these genetic alterations.

Purpose of the Study:

  • * To identify an agent capable of overcoming chemoresistance caused by Bax or p53 deficiency.
  • * To elucidate the molecular mechanisms underlying genistein-induced cell death in cancer cells with deficient Bax or p53.

Main Methods:

  • * Utilized immunoblotting and flow-cytometry analysis to assess cell death.
  • * Employed gene interference techniques, including knockdown (KD) and knockout (KO) models (HCT116, DU145 cells).
  • * Investigated the roles of Bak, Apoptosis-Inducing Factor (AIF), and endonuclease G (endoG) in genistein-induced apoptosis.

Main Results:

  • * Genistein induced Bax/p53-independent apoptosis in cancer cells lacking Bax or p53 but expressing wild-type Bak.
  • * Bak knockdown only partially reduced genistein-induced apoptosis, indicating involvement of other pathways.
  • * Release of AIF and endoG contributed to cell death independently of Bak activation.
  • * A combination of AIF, endoG, and Bak knockdown almost completely abolished genistein-induced apoptosis.
  • * The Akt-Bid pathway mediated both Bak-dependent (caspase-dependent) and AIF/endoG-dependent (caspase-independent) cell death.
  • * Caspase-3 activation created a positive feedback loop, enhancing AIF/endoG release and Bak activation.

Conclusions:

  • * Genistein effectively induces cancer cell death through Bax/p53-independent mechanisms.
  • * Caspase-3 activation, via the Akt-Bid pathway, initiates genistein-induced apoptosis through a positive feedback loop.
  • * Genistein shows promise as a therapeutic agent for overcoming chemoresistance in cancers with dysfunctional Bax and p53 pathways.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K